Transcranial Magnetic Stimulation trials

Advantage of Cerebellar Transcranial Magnetic Stimulation in Alzheimer's Diseases (ACT-AD)

RecruitingNCT06669182Phase: NAStarted 2025-01-07

Summary

Alzheimer's Disease (AD) is the primary cause of dementia, with its prominent feature being cognitive decline. The cerebellum plays a crucial role in cognitive processing, making it a potential target

Eligibility

Sex
ALL
Min Age
50 Years
Max Age
85 Years

Locations

Xijing Hospital of Air Force Military Medical UniversityXi'an, Shaanxi, China
Tangdu Hospital of Air Force Military Medical UniversityXi'an, Shannxi, China
The First Affiliated Hospital of Xi'an Medical UniversityXi'an, Shannxi, China
The Third Hospital of Xi'anXi'an, Shannxi, China

View full study details on ClinicalTrials.gov

clinicaltrials.gov/study/NCT06669182